Life Science Investing FDA Approves Guardant360® CDx as Companion Diagnostic for Eli Lilly and Company's Inluriyo for Treatment of ESR1-mutated Advanced Breast Cancer 29 September
Life Science Investing Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership 11 September
